ClinicalTrials.Veeva

Menu

Immunophenotyping of Acute b Cell Lymphoblstic Leukemia

S

South Egypt Cancer Institute

Status

Unknown

Conditions

Acute Leukemia

Treatments

Other: stastical analysis

Study type

Observational

Funder types

Other

Identifiers

NCT04084327
acute b All

Details and patient eligibility

About

To study the immunophenotyping pattern of acute B lymphoblastic leukemia in south Egypt Cancer Institute iand its correlation with disease outcome

Full description

study the immunophenotyping pattern of acute B lymphoblastic leukemia in south Egypt Cancer Institute from 2009 -2019 and its correlation with disease outcome

Enrollment

50 estimated patients

Sex

All

Ages

12 months to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • New cases admitted to SECI Who didn't receive treatment.Age above 1 years old.

Exclusion criteria

  • Cases who received treatment Patients below 1 years old.Patients diagnosed as AML or T-ALL

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems